Rajnish Wellness Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Rajnish Wellness Ltd is ₹ 0.49 as of 05 May 15:30 . The P/E Ratio of Rajnish Wellness Ltd is 0 as of December 2023 .The P/E Ratio of Sanofi India Ltd is 30.8 as of December 2023 . The Market Cap of Rajnish Wellness Ltd is ₹ 0 crore as of December 2023 .The Market Cap of Sanofi India Ltd is ₹ 18578 crore as of December 2023 . The Revenue of Rajnish Wellness Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Sanofi India Ltd is ₹ 578.9 crore as of Jun '24 . The EBITDA of Rajnish Wellness Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Sanofi India Ltd is ₹ 178.5 crore as of Jun '24 . The Net Profit of Rajnish Wellness Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Sanofi India Ltd is ₹ 136.6 crore as of Jun '24 . The dividend payout of Rajnish Wellness Ltd changed from 0 % to 0 % over 10 quarters. This represents a CAGR of 0.0% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Rajnish Wellness Ltd

Rajnish Wellness Limited was originally incorporated on June 13, 2015 as a Private Limited Company under the name and style of 'Rajnish Hot Deals Private Limited'.
Subsequently, the Company was converted into a Public Limited Company on February 01, 2018 and was renamed to 'Rajnish Wellness Limited' on February 09, 2018. The Company is currently engaged in the business of selling various products in the categories ranging from consumer durables to ayurvedic personal care products.
The Company's major focus area is sexual wellness, energy revitalization and personal care products.
Changing lifestyle and awareness of health and wellness is increasing demand for sexual wellness and energy revitalization products.
Current product portfolio is concentratedon ayuvedic products.

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Rajnish Wellness Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Rajnish Wellness Ltd or Sanofi India Ltd?

Market cap of Rajnish Wellness Ltd is 50 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Rajnish Wellness Ltd and Sanofi India Ltd?

The stock performance of Rajnish Wellness Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Rajnish Wellness Ltd and Sanofi India Ltd?

As of May 5, 2026, the Rajnish Wellness Ltd stock price is INR ₹0.5. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Rajnish Wellness Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Rajnish Wellness Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.